HeartSciences Current Ratio 2022-2025 | HSCS
HeartSciences current ratio from 2022 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| HeartSciences Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-07-31 | $0.00B | $0.00B | 1.47 |
| 2025-04-30 | $0.00B | $0.00B | 0.59 |
| 2025-01-31 | $0.00B | $0.00B | 1.02 |
| 2024-10-31 | $0.01B | $0.00B | 1.72 |
| 2024-07-31 | $0.01B | $0.00B | 4.49 |
| 2024-04-30 | $0.01B | $0.00B | 4.20 |
| 2024-01-31 | $0.01B | $0.00B | 5.09 |
| 2023-10-31 | $0.00B | $0.00B | 0.51 |
| 2023-07-31 | $0.00B | $0.00B | 1.07 |
| 2023-04-30 | $0.00B | $0.00B | 1.47 |
| 2023-01-31 | $0.00B | $0.00B | 1.45 |
| 2022-10-31 | $0.00B | $0.00B | 1.32 |
| 2022-07-31 | $0.01B | $0.00B | 3.53 |
| 2022-04-30 | $0.00B | $0.00B | 0.56 |
| 2022-01-31 | $0.00B | 0.00 | |
| 2021-10-31 | $0.00B | 0.00 | |
| 2021-07-31 | $0.00B | 0.00 | |
| 2021-04-30 | $0.00B | $0.00B | 1.47 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.007B | $0.000B |
| Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made available on either a hardware agnostic cloud-based platform or its proprietary MyoVista? wavECG(TM) device, to help identify cardiovascular disease in any care setting worldwide in a manner to best suit different care providers. HeartSciences' first product candidate for FDA clearance, the MyoVista? wavECG(TM), or the MyoVista(R), is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.700B | 42.44 |
| Tempus AI (TEM) | United States | $12.562B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $8.471B | 68.91 |
| Doximity (DOCS) | United States | $8.256B | 33.99 |
| IRhythm Technologies (IRTC) | United States | $5.440B | 0.00 |
| Hinge Health (HNGE) | United States | $3.912B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.797B | 62.83 |
| Privia Health (PRVA) | United States | $3.064B | 191.62 |
| Heartflow (HTFL) | United States | $2.255B | 0.00 |
| Omnicell (OMCL) | United States | $1.968B | 40.24 |
| 10x Genomics (TXG) | United States | $1.957B | 0.00 |
| Azenta (AZTA) | United States | $1.623B | 66.60 |
| Enovis (ENOV) | United States | $1.514B | 7.95 |
| Clover Health Investments (CLOV) | United States | $1.395B | 0.00 |
| Schrodinger (SDGR) | United States | $1.330B | 0.00 |
| Phreesia (PHR) | United States | $0.980B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.839B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.760B | 0.00 |
| Claritev (CTEV) | United States | $0.619B | 0.00 |
| CapsoVision (CV) | United States | $0.602B | 0.00 |
| Talkspace (TALK) | United States | $0.581B | 117.00 |
| Standard BioTools (LAB) | United States | $0.558B | 0.00 |
| Veradigm (MDRX) | United States | $0.539B | 0.00 |
| Evolent Health (EVH) | United States | $0.460B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.413B | 0.00 |
| Carlsmed (CARL) | United States | $0.344B | 0.00 |
| TruBridge (TBRG) | United States | $0.338B | 15.55 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.321B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.280B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.268B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.174B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.161B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.157B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.149B | 0.00 |
| CareCloud (CCLD) | United States | $0.139B | 7.65 |
| Pulmonx (LUNG) | United States | $0.104B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.087B | 0.00 |
| HeartBeam (BEAT) | United States | $0.079B | 0.00 |
| Outset Medical (OM) | United States | $0.076B | 0.00 |
| American Well (AMWL) | United States | $0.075B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.068B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.066B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.044B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.037B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.025B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.014B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |